Oral administration of a CH(2)Cl(2)-MeOH (1:1) extract of Scaphyglottis livida produced dose-dependent antinociceptive and anti-inflammatory effects when tested in mice and rats using the hot-plate (150-600 mg/kg) and
carrageenan-induced
inflammation (150-600 mg/kg) models, respectively.
Morphine (1.5-6 mg/kg, p.o.) and
indomethacin (10-40 mg/kg, p.o.) were used as positive controls, respectively. Four compounds were isolated from the active extract of Scaphyglottis livida, namely 5alpha-lanosta-24,24-dimethyl-9(11),25-dien-3beta-ol (LDD), 24,24,dimethyl-9,19-cyclolanosta-9(11),25-dien-3-one (cyclobalanone),
gigantol and 3,4'-dihydroxy-3',4,5-trimethoxybibenzyl (DTB). LDD and
gigantol (25-100 mg/kg, p.o.) significantly increased the hot-plate latency in comparison to vehicle-treated mice and decreased
carrageenan-induced
inflammation in rats. The antinociception provoked by LDD and
gigantol was partially blocked by
naloxone (1mg/kg, i.p.). However, pretreatment with
L-NAME (100 mg/kg, i.p.) and
glibenclamide (10 mg/kg, i.p.) did not affect the antinociceptive response induced by LDD or
gigantol suggesting that their pharmacological effect could be partially due to activation of
opioid receptors. Moreover, a CH(2)Cl(2)-MeOH (1:1) extract of Maxillaria densa reduced
acetic acid-induced abdominal writhes but was not able to produce antinociception in the hot-plate assay. Two compounds were isolated from the active extract of Maxillaria densa, namely
fimbriol A and
erianthridin. Both compounds partially reduced
acetic acid-induced writhes. The results tend to support the popular use of this species in
folk medicine for treatment of painful complaints.